MYGN 28.6 (+2.51%)
US62855J1043• Medical Diagnostics & Research• Diagnostics & Research
Intro Stories Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. MYGN

Myriad Genetics (MYGN) Stories

Here is a selected set of our story library related to Myriad Genetics (MYGN).

Post

Myriad Genetics (MYGN) - Piotroski F-Score Analysis for Year 2023 (Final Score: 3/9)

Myriad Genetics (MYGN) 2023 Piotroski F-Score analysis reveals financial struggles with a score of 3/9 based on profitability, liquidity, and efficiency criteria.

2024-06-07